The US obesity debate will be opened by the Olympics. what you need to know
The US obesity debate will be opened by the Olympics. what you need to know
The focus of diet hacks and online celebrity debates in recent months has been the diabetes drug Ozempic and his weight-loss analogue, Wegovy. It is now the responsibility of doctors to organize information when negotiating their relationship with society’s complex and often dangerous diet drugs.
Do new drugs really work? are you safe Is it moral to seek semaglutide as a weight loss aid when the US Food and Drug Administration still reports semaglutide deficiencies in both drugs?
The answer may depend on why you are taking them and whether or not you can continue taking them. Professor and head of the Department of Endocrinology, Christoph Buttner, said Ozempic and Wegovy appear to be safer than previous weight-loss drugs.Both drugs differ from each other in their profiles. Except for Munjaro, which is currently approved to treat diabetes but will soon be approved to treat weight loss, “so far there doesn’t seem to be anything really like it,” Büttner said. .
Wegovy and Ozempic are chronic drugs and, like many other drugs, are intended to be taken over a long period of time. This includes both benefits and risks. As the saying goes, according to Bhuttner, there are no free lunches.
What are Wegovy and Olympic? how do they work
Semaglutide is the same active ingredient in both Wegovy and Ozempic, but Wegovy has a higher concentration and is FDA approved for weight loss only. Ozempic was originally approved to treat type 2 diabetes, but may be used off-label to help with weight loss. Both are once-weekly injectables manufactured by the same pharmaceutical company, Novo Nordisk, similar to using the EpiPen.
Semaglutide stabilizes blood sugar levels by inhibiting insulin synthesis. It also reduces your appetite and slows down the passage of food through your stomach, changing the way your body perceives hunger and fullness.
Ozempic’s main goal is to control blood sugar levels while reducing the risk of heart disease, stroke, and other health events that people with diabetes are likely to experience. The body of people with type 2 diabetes cannot process insulin properly. A major goal of type 2 diabetes treatment is glycemic control, and semaglutide excels in these studies.
Wegovy helps you lose weight in adults with a body mass index (BMI) greater than 27 and those with at least one health problem, such as: B. Adults with hypertension and BMI greater than 30 according to the approved use. People without diabetes who received Wegovy lost an average of 12.4% of their weight compared to those who received a placebo, according to the FDA’s approval notice.
However, the growing popularity of Ozempic and Wegovy has long raised concerns about the stigma attached to weight loss drugs and being overweight. There were also unexpected effects such as B. Shortage of medicines.
Due to the popularity of the recipe, it is out of stock. Demand for Wegovy was so high that some people who couldn’t get it switched to Ozempic, a lower-dose sister drug for diabetes treatment administered off-label by doctors.
Wegovy helps weight loss for adults with a body mass index (BMI) greater than 27 and people with at least one health problem, such as: B. Adults with hypertension and BMI greater than 30 according to the approved use. Her Wegovy-treated people without diabetes lost an average of 12.4% of their weight compared to those who received a placebo, according to the FDA’s approval notice.
However, the growing popularity of Ozempic and Wegovy has long raised concerns about the stigma attached to weight loss drugs and being overweight. There were also unexpected effects such as B. Shortage of medicines. Due to the popularity of the recipe, it is out of stock.
Demand for Wegovy was so high that some people who couldn’t get it switched to Ozempic, a lower-dose sister drug for diabetes treatment administered off-label by doctors.
The same active ingredient is also found in Libersus, a diabetes medication that must be taken orally. Other drugs include Vicoza, Trulicity and Bydureon. According to Everyday Health, if a diabetic has trouble filling prescriptions, it may be one of the options for her.
The Dangerous Past and Uncertain Future of Dietary Supplements
Tigress Osborn, president of the National Association to Advance Fat Acceptance, is familiar with the semaglutide epidemic. Osborn disagrees with the idea that obesity is a disease, as do many body positive and fat rights activists, and even certain medical professionals. Some of the same medical frameworks were also used in previous waves of weight loss supplements.These include fenfen, the nickname for the appetite suppressant. It was eventually withdrawn from the market because it caused heart damage in
“I’ve heard from you before,” Osborne said of the current wave of weight-loss drugs’ widespread advocacy. will do.”
According to Büttner, some older drugs caused not only heart problems, but also psychiatric side effects such as depression. I know there is.
“The effects on depression and suicidal ideation are normal when you administer drugs that act in the brain,” Büttner added. Both Ozempic and Wegovy work in the brain responsible for the ability to suppress appetite. But, he says, “the signals are very different” from GLP-1 receptor agonists in certain areas of the brain. Stomach pain, nausea, vomiting, diarrhea, and other stomach upsets are common side effects of both Ozempic and Wegovy. Serious side effects, including pancreatitis, have been documented but are rare. Since weight loss also leads to a reduction in facial fat, some people claim that they lost some of their facial fat to give them a younger and more attractive appearance, or “Ozempic Face.”
And the real reason is the stigma attached to obesity and its ongoing negative health effects. Weight studies have questioned whether weight loss recommendations based solely on BMI make sense for health. Persistent stereotypes of being big and increasing pressure to stay slim are forcing people to choose between trying new ways to lose weight or staying current, Osborne said. It is Here are her words: Your medicine is really changing our minds. “How would you choose between these options?”
Constant availability is a problem for those who decide to use these drugs. Current shortages aside, whether insurance companies are willing to pay for these prescriptions will affect future availability. One example of how cultural stigma makes managing body health more difficult, even when trying to lose weight, is that many patients have insurance to pay for prescription drugs when they are diagnosed with obesity. is difficult. As more weight loss drugs become available, Medicare and insurance companies may face additional pressure to change policies in the future. Access is a problem for those who need semaglutide for their health but are less well-known or wealthy. Wegovy’s monthly out-of-pocket costs are about $1,400, according to NPR. Failure to replenish a patient’s semaglutide prescription can result in health problems such as untreated diabetes and rapid weight gain.
Once patients stop taking semaglutide, the weight lost while taking it is usually regained, so it must be taken continuously to be successful.Increased mortality is associated with weight cycling-related health risks. of he is one. It occurs when people continuously lose or gain weight through diets or other practices. On the other hand, catching a cold after taking medication to control blood sugar levels may increase your risk of other health problems, such as stroke.